# Efficacy and Safety of Cefditoren Pivoxil Versus Ciprofloxacin in Acute Uncomplicated Cystitis

> **NCT00598403** · PHASE3 · COMPLETED · sponsor: **Tedec-Meiji Farma, S.A.** · enrollment: 611 (actual)

## Conditions studied

- Urinary Tract Infections

## Interventions

- **DRUG:** cefditoren pivoxil
- **DRUG:** Ciprofloxacin

## Key facts

- **NCT ID:** NCT00598403
- **Lead sponsor:** Tedec-Meiji Farma, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-12
- **Final completion:** 2010-06
- **Target enrollment:** 611 (ACTUAL)
- **Last updated:** 2010-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00598403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00598403, "Efficacy and Safety of Cefditoren Pivoxil Versus Ciprofloxacin in Acute Uncomplicated Cystitis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00598403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*